Alignment Healthcare Q4 revenue rises 50.7% to $701.2 million; net loss narrows
Alignment Healthcare reported fourth-quarter and full-year 2024 results on February 27, 2025, with revenue growth of 50.7% in the quarter and 48.3% for the year. Net losses narrowed from the prior year, and the company issued 2025 guidance of $3.72 billion to $3.78 billion in revenue and $35 million to $60 million in adjusted EBITDA.
Key points
- Q4 2024 total revenue was $701.2 million, up 50.7% year over year; net loss was $(31.1) million versus $(47.2) million a year earlier.
- Full-year 2024 total revenue was $2,703.6 million, up 48.3%; net loss was $(128.1) million versus $(148.2) million in 2023.
- 2025 guidance: revenue of $3.72 billion to $3.78 billion and adjusted EBITDA of $35 million to $60 million.
- Health plan membership was about 189,100 at December 31, 2024, up 58.6% year over year.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.